A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
Conditions
Non-cystic Fibrosis Bronchiectasis · Chronic Obstructive Pulmonary Disease
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Alabama at Birmingham, Birmingham, Alabama, United States
Accel Research Site - Achieve - Birmingham - ERN - PPDS, Vestavia Hills, Alabama, United States
Stanford Center for Excellence in Pulmonary Biology, Palo Alto, California, United States
University of Kansas Medical Center-Kansas City-3901 Rainbow Blvd, Kansas City, Kansas, United States
University of North Carolina Clinical Research Center, Chapel Hill, North Carolina, United States
UPMC Montefiore Hospital, Pittsburgh, Pennsylvania, United States
TTS Research, Boerne, Texas, United States
Study leads
Clinical Trials
Study Director
Genentech, Inc.